Cargando…

Inhibition of Prostate Cancer DU-145 Cells Proliferation by Anthopleura anjunae Oligopeptide (YVPGP) via PI3K/AKT/mTOR Signaling Pathway

We investigated the antitumor mechanism of Anthopleura anjunae oligopeptide (AAP-H, YVPGP) in prostate cancer DU-145 cells in vitro and in vivo. Results indicated that AAP-H was nontoxic and exhibited antitumor activities. Cell cycle analysis indicated that AAP-H may arrest DU-145 cells in the S pha...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaojuan, Tang, Yunping, Yu, Fangmiao, Sun, Yu, Huang, Fangfang, Chen, Yan, Yang, Zuisu, Ding, Guofang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165336/
https://www.ncbi.nlm.nih.gov/pubmed/30208576
http://dx.doi.org/10.3390/md16090325
_version_ 1783359812851990528
author Li, Xiaojuan
Tang, Yunping
Yu, Fangmiao
Sun, Yu
Huang, Fangfang
Chen, Yan
Yang, Zuisu
Ding, Guofang
author_facet Li, Xiaojuan
Tang, Yunping
Yu, Fangmiao
Sun, Yu
Huang, Fangfang
Chen, Yan
Yang, Zuisu
Ding, Guofang
author_sort Li, Xiaojuan
collection PubMed
description We investigated the antitumor mechanism of Anthopleura anjunae oligopeptide (AAP-H, YVPGP) in prostate cancer DU-145 cells in vitro and in vivo. Results indicated that AAP-H was nontoxic and exhibited antitumor activities. Cell cycle analysis indicated that AAP-H may arrest DU-145 cells in the S phase. The role of the phosphatidylinositol 3-kinase/protein kinase B/mammalian rapamycin target protein (PI3K/AKT/mTOR) signaling pathway in the antitumor mechanism of APP-H was investigated. Results showed that AAP-H treatment led to dose-dependent reduction in the levels of p-AKT (Ser473), p-PI3K (p85), and p-mTOR (Ser2448), whereas t-AKT and t-PI3K levels remained unaltered compared to the untreated DU-145 cells. Inhibition of PI3K/AKT/mTOR signaling pathway in the DU-145 cells by employing inhibitor LY294002 (10 μM) or rapamycin (20 nM) effectively attenuated AAP-H-induced phosphorylation of AKT and mTOR. At the same time, inhibitor addition further elevated AAP-H-induced cleaved-caspase-3 levels. Furthermore, the effect of AAP-H on tumor growth and the role of the PI3K/AKT/mTOR signaling pathway in nude mouse model were also investigated. Immunohistochemical analysis showed that activated AKT, PI3K, and mTOR levels were reduced in DU-145 xenografts. Western blotting showed that AAP-H treatment resulted in dose-dependent reduction in p-AKT (Ser473), p-PI3K (p85), and p-mTOR (Ser2448) levels, whereas t-AKT and t-PI3K levels remained unaltered. Similarly, Bcl-xL levels decreased, whereas that of Bax increased after AAP-H treatment. AAP-H also increased initiator (caspase 8 and 9) and executor caspase (caspase 3 and 7) levels. Therefore, the antitumor mechanism of APP-H on DU-145 cells may involve regulation of the PI3K/AKT/mTOR signaling pathway, which eventually promotes apoptosis via mitochondrial and death receptor pathways. Thus, the hydrophobic oligopeptide (YVPGP) can be developed as an adjuvant for the prevention or treatment of prostate cancer in the future.
format Online
Article
Text
id pubmed-6165336
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-61653362018-10-11 Inhibition of Prostate Cancer DU-145 Cells Proliferation by Anthopleura anjunae Oligopeptide (YVPGP) via PI3K/AKT/mTOR Signaling Pathway Li, Xiaojuan Tang, Yunping Yu, Fangmiao Sun, Yu Huang, Fangfang Chen, Yan Yang, Zuisu Ding, Guofang Mar Drugs Article We investigated the antitumor mechanism of Anthopleura anjunae oligopeptide (AAP-H, YVPGP) in prostate cancer DU-145 cells in vitro and in vivo. Results indicated that AAP-H was nontoxic and exhibited antitumor activities. Cell cycle analysis indicated that AAP-H may arrest DU-145 cells in the S phase. The role of the phosphatidylinositol 3-kinase/protein kinase B/mammalian rapamycin target protein (PI3K/AKT/mTOR) signaling pathway in the antitumor mechanism of APP-H was investigated. Results showed that AAP-H treatment led to dose-dependent reduction in the levels of p-AKT (Ser473), p-PI3K (p85), and p-mTOR (Ser2448), whereas t-AKT and t-PI3K levels remained unaltered compared to the untreated DU-145 cells. Inhibition of PI3K/AKT/mTOR signaling pathway in the DU-145 cells by employing inhibitor LY294002 (10 μM) or rapamycin (20 nM) effectively attenuated AAP-H-induced phosphorylation of AKT and mTOR. At the same time, inhibitor addition further elevated AAP-H-induced cleaved-caspase-3 levels. Furthermore, the effect of AAP-H on tumor growth and the role of the PI3K/AKT/mTOR signaling pathway in nude mouse model were also investigated. Immunohistochemical analysis showed that activated AKT, PI3K, and mTOR levels were reduced in DU-145 xenografts. Western blotting showed that AAP-H treatment resulted in dose-dependent reduction in p-AKT (Ser473), p-PI3K (p85), and p-mTOR (Ser2448) levels, whereas t-AKT and t-PI3K levels remained unaltered. Similarly, Bcl-xL levels decreased, whereas that of Bax increased after AAP-H treatment. AAP-H also increased initiator (caspase 8 and 9) and executor caspase (caspase 3 and 7) levels. Therefore, the antitumor mechanism of APP-H on DU-145 cells may involve regulation of the PI3K/AKT/mTOR signaling pathway, which eventually promotes apoptosis via mitochondrial and death receptor pathways. Thus, the hydrophobic oligopeptide (YVPGP) can be developed as an adjuvant for the prevention or treatment of prostate cancer in the future. MDPI 2018-09-11 /pmc/articles/PMC6165336/ /pubmed/30208576 http://dx.doi.org/10.3390/md16090325 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Li, Xiaojuan
Tang, Yunping
Yu, Fangmiao
Sun, Yu
Huang, Fangfang
Chen, Yan
Yang, Zuisu
Ding, Guofang
Inhibition of Prostate Cancer DU-145 Cells Proliferation by Anthopleura anjunae Oligopeptide (YVPGP) via PI3K/AKT/mTOR Signaling Pathway
title Inhibition of Prostate Cancer DU-145 Cells Proliferation by Anthopleura anjunae Oligopeptide (YVPGP) via PI3K/AKT/mTOR Signaling Pathway
title_full Inhibition of Prostate Cancer DU-145 Cells Proliferation by Anthopleura anjunae Oligopeptide (YVPGP) via PI3K/AKT/mTOR Signaling Pathway
title_fullStr Inhibition of Prostate Cancer DU-145 Cells Proliferation by Anthopleura anjunae Oligopeptide (YVPGP) via PI3K/AKT/mTOR Signaling Pathway
title_full_unstemmed Inhibition of Prostate Cancer DU-145 Cells Proliferation by Anthopleura anjunae Oligopeptide (YVPGP) via PI3K/AKT/mTOR Signaling Pathway
title_short Inhibition of Prostate Cancer DU-145 Cells Proliferation by Anthopleura anjunae Oligopeptide (YVPGP) via PI3K/AKT/mTOR Signaling Pathway
title_sort inhibition of prostate cancer du-145 cells proliferation by anthopleura anjunae oligopeptide (yvpgp) via pi3k/akt/mtor signaling pathway
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165336/
https://www.ncbi.nlm.nih.gov/pubmed/30208576
http://dx.doi.org/10.3390/md16090325
work_keys_str_mv AT lixiaojuan inhibitionofprostatecancerdu145cellsproliferationbyanthopleuraanjunaeoligopeptideyvpgpviapi3kaktmtorsignalingpathway
AT tangyunping inhibitionofprostatecancerdu145cellsproliferationbyanthopleuraanjunaeoligopeptideyvpgpviapi3kaktmtorsignalingpathway
AT yufangmiao inhibitionofprostatecancerdu145cellsproliferationbyanthopleuraanjunaeoligopeptideyvpgpviapi3kaktmtorsignalingpathway
AT sunyu inhibitionofprostatecancerdu145cellsproliferationbyanthopleuraanjunaeoligopeptideyvpgpviapi3kaktmtorsignalingpathway
AT huangfangfang inhibitionofprostatecancerdu145cellsproliferationbyanthopleuraanjunaeoligopeptideyvpgpviapi3kaktmtorsignalingpathway
AT chenyan inhibitionofprostatecancerdu145cellsproliferationbyanthopleuraanjunaeoligopeptideyvpgpviapi3kaktmtorsignalingpathway
AT yangzuisu inhibitionofprostatecancerdu145cellsproliferationbyanthopleuraanjunaeoligopeptideyvpgpviapi3kaktmtorsignalingpathway
AT dingguofang inhibitionofprostatecancerdu145cellsproliferationbyanthopleuraanjunaeoligopeptideyvpgpviapi3kaktmtorsignalingpathway